Clinical Trial Update: Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing capecitabine plus cisplatin versus capecitabine plus paclitaxel as first-line regimens for advanced esophageal squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Samsung Medical Center | Conditions: First Line Chemotherapy, Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel | Phase 2 | Status: UNKNOWN